CD247 and cancer: T cells bearing a CAR consisting of the full human NKG2D receptor fused to the intracellular domain of CD3z (CYAD-01 T cells) specifically recognize and kill cancer cell lines derived from hematological and solid tumors in vitro and in vivo.